RU2016133247A3 - - Google Patents

Download PDF

Info

Publication number
RU2016133247A3
RU2016133247A3 RU2016133247A RU2016133247A RU2016133247A3 RU 2016133247 A3 RU2016133247 A3 RU 2016133247A3 RU 2016133247 A RU2016133247 A RU 2016133247A RU 2016133247 A RU2016133247 A RU 2016133247A RU 2016133247 A3 RU2016133247 A3 RU 2016133247A3
Authority
RU
Russia
Application number
RU2016133247A
Other languages
Russian (ru)
Other versions
RU2016133247A (ru
RU2785598C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016133247A publication Critical patent/RU2016133247A/ru
Publication of RU2016133247A3 publication Critical patent/RU2016133247A3/ru
Application granted granted Critical
Publication of RU2785598C2 publication Critical patent/RU2785598C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2016133247A 2014-01-15 2015-01-14 Rsv-специфичные антитела и их функциональные части RU2785598C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461927819P 2014-01-15 2014-01-15
US61/927,819 2014-01-15
PCT/US2015/011391 WO2015108967A2 (en) 2014-01-15 2015-01-14 Rsv-specific antibodies and functional parts thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2022130632A Division RU2022130632A (ru) 2014-01-15 2015-01-14 Rsv-специфичные антитела и их функциональные части

Publications (3)

Publication Number Publication Date
RU2016133247A RU2016133247A (ru) 2018-02-20
RU2016133247A3 true RU2016133247A3 (enExample) 2019-01-16
RU2785598C2 RU2785598C2 (ru) 2022-12-09

Family

ID=

Also Published As

Publication number Publication date
WO2015108967A8 (en) 2015-10-01
LT3094353T (lt) 2020-08-10
NL301228I2 (nl) 2023-09-13
BR112016015044A2 (pt) 2017-09-19
CA2933200A1 (en) 2015-07-23
MX2016008639A (es) 2017-02-15
BR112016015044A8 (pt) 2023-04-11
US20250179153A1 (en) 2025-06-05
US12173050B2 (en) 2024-12-24
EP4353316A2 (en) 2024-04-17
CY2023011I1 (el) 2023-11-15
DK3094353T3 (da) 2020-06-02
AU2025201056A1 (en) 2025-03-06
SI3094353T1 (sl) 2020-07-31
KR102188437B1 (ko) 2020-12-08
AU2021204339A1 (en) 2021-07-22
CY2023011I2 (el) 2023-11-15
US20230365660A1 (en) 2023-11-16
AU2015206570A1 (en) 2016-07-14
JP2025063143A (ja) 2025-04-15
AU2020203831A1 (en) 2020-07-02
JP2023052693A (ja) 2023-04-11
EP3741390A1 (en) 2020-11-25
EP3094353B1 (en) 2020-04-01
WO2015108967A2 (en) 2015-07-23
RU2016133247A (ru) 2018-02-20
ES2795727T3 (es) 2020-11-24
JP2020103293A (ja) 2020-07-09
CA2933200C (en) 2025-05-06
LUC00305I2 (enExample) 2025-09-22
EP4353316A3 (en) 2024-08-21
HUS2300019I1 (hu) 2023-05-28
LTPA2023514I1 (enExample) 2023-05-25
RS60387B1 (sr) 2020-07-31
WO2015108967A3 (en) 2015-09-03
US11661449B2 (en) 2023-05-30
JP6836398B2 (ja) 2021-03-03
FIC20230016I1 (fi) 2023-04-26
PL3094353T3 (pl) 2020-09-07
EP3094353A2 (en) 2016-11-23
FR23C1016I1 (fr) 2023-06-23
EP3094353A4 (en) 2017-09-06
NL301228I1 (enExample) 2023-05-03
NO2023016I1 (no) 2023-04-25
US20220098285A1 (en) 2022-03-31
US20160340414A1 (en) 2016-11-24
TWI705974B (zh) 2020-10-01
PT3094353T (pt) 2020-06-08
CY1123425T1 (el) 2021-12-31
MX374517B (es) 2025-03-06
LTC3094353I2 (enExample) 2025-07-10
US11186628B2 (en) 2021-11-30
US20190106482A1 (en) 2019-04-11
CN105916520A (zh) 2016-08-31
KR20160104018A (ko) 2016-09-02
TW201612191A (en) 2016-04-01
HUE048855T2 (hu) 2020-08-28
HRP20200607T1 (hr) 2020-07-10
US10689437B2 (en) 2020-06-23
US20200331989A1 (en) 2020-10-22
CN116355080A (zh) 2023-06-30
JP2017504321A (ja) 2017-02-09
HK1225992A1 (en) 2017-09-22
FR23C1016I2 (fr) 2026-05-29
AU2021204339B2 (en) 2024-11-14
SMT202000282T1 (it) 2020-07-08
ES2795727T9 (en) 2026-01-21

Similar Documents

Publication Publication Date Title
BR112016016761A2 (enExample)
BR112016015519A2 (enExample)
BR112016015890A2 (enExample)
BR112016016490A2 (enExample)
BR112016015518A2 (enExample)
BR112016016546A2 (enExample)
BR112016014949A2 (enExample)
BR112016016612A2 (enExample)
BR112016016421A2 (enExample)
BR112016016106A2 (enExample)
BR112016012568A2 (enExample)
BR112016016751A2 (enExample)
BR112016016558A2 (enExample)
BR112016015676A2 (enExample)
BR112016015915A2 (enExample)
BR112015029172A2 (enExample)
BR112016016468A2 (enExample)
BR112016016389A2 (enExample)
BR112016016459A2 (enExample)
BR112016003522A2 (enExample)
BR112016015935A2 (enExample)
BR112016014482A2 (enExample)
BR112016015054A2 (enExample)
BR112016015896A2 (enExample)
BR112016015538A2 (enExample)